Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study

BACKGROUND: No real‐world data exist on outcomes in patients on anticoagulants and concomitant antiarrhythmic medications. This study aims to compare the safety and effectiveness of apixaban and warfarin, first in patients with nonvalvular atrial fibrillation (NVAF) and then in patients on concurren...

Descripción completa

Detalles Bibliográficos
Autores principales: Wanat, Matthew A., Wang, Xin, Paranjpe, Rutugandha, Chen, Hua, Johnson, Michael L., Fleming, Marc L., Abughosh, Susan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles: Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781914/
https://www.ncbi.nlm.nih.gov/pubmed/31624787
http://dx.doi.org/10.1002/rth2.12221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781914/
https://www.ncbi.nlm.nih.gov/pubmed/31624787
http://dx.doi.org/10.1002/rth2.12221

Ejemplares similares